Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK1903 in Patients With Dyslipidemia
NCT00847197Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-1903 in dyslipidemia, sponsored by Merck & Co.. Started Jun 2008; status: completed.
02
Drugs
MK-1903
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00847197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847197.